[EN] COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES<br/>[FR] COMPOSITIONS ET PROCÉDÉS ASSOCIÉS À DES OXYDES DISSOUS
申请人:NATURAL EXTRACTION SYS LLC
公开号:WO2021042001A1
公开(公告)日:2021-03-04
Various aspects of this patent document relate to compositions that comprise an anion that is the conjugate base of a hydrophobic molecule that has a pKa, for example, of at least 7 and no greater than 12. These compositions display improved properties when formulated to interact with an organism because the anions carry negative charges that allows them to both dissolve in water-miscible liquids and maximize their surface area. Interaction with an organism results in at least partial conversion of the anion into the hydrophobic molecule after which the hydrophobic molecule partitions out of a water-miscible liquid and into the organism.
[EN] METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES<br/>[FR] PROCÉDÉS LIÉS À DES AGENTS BIOACTIFS QUI CONVERTISSENT DES ANIONS EN MOLÉCULES
申请人:NATURAL EXTRACTION SYS LLC
公开号:WO2021158573A1
公开(公告)日:2021-08-12
Various aspects of this patent document relate to bioactive compositions comprising anions that are converted into hydrophobic bioactive molecules either ex vivo prior to administration to a subject or in situ subsequent to administration to a subject. Such compositions display improved bioavailability and pharmacokinetics relative to compositions that comprise the hydrophobic bioactive molecules instead of the anions.
[EN] COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES<br/>[FR] COMPOSITIONS ASSOCIÉES À DES AGENTS BIOACTIFS QUI CONVERTISSENT DES ANIONS EN MOLÉCULES
申请人:NATURAL EXTRACTION SYS LLC
公开号:WO2021158575A1
公开(公告)日:2021-08-12
Various aspects of this patent document relate to bioactive compositions comprising anions that are converted into hydrophobic bioactive molecules either ex vivo prior to administration to a subject or in situ subsequent to administration to a subject. Such compositions display improved bioavailability and pharmacokinetics relative to compositions that comprise the hydrophobic bioactive molecules instead of the anions.